Healthcare real estate transactions — including sale-leasebacks, joint ventures, and campus monetizations — can directly affect a health system’s bond ratings by altering key financial ratios that credit agencies use to assess creditworthiness.
Why It Matters
Bond ratings determine the interest rate a health system pays when accessing capital markets. A single rating notch downgrade — from, say, A to A- — can increase borrowing costs by 25 to 50 basis points across a bond portfolio, adding millions in annual debt service on a $500 million issuance. For health systems already operating on thin margins, that difference is material.
Credit agencies such as Moody’s, S&P Global, and Fitch evaluate not just financial performance but capital structure decisions, including how real estate assets are held, leveraged, or divested. A real estate transaction that appears operationally neutral can trigger rating scrutiny if it changes leverage ratios, operating lease obligations, or liquidity positions in ways the agency views as credit-negative.
How It Works
Rating agencies assess several financial metrics when reviewing a health system’s credit profile. The most relevant to real estate transactions include debt-to-capitalization, days cash on hand, operating margin, and — increasingly under ASC 842 accounting standards — operating lease obligations. ASC 842 requires organizations to recognize operating leases on the balance sheet, meaning a sale-leaseback transaction that converts owned real estate to leased space now creates a visible liability where none previously existed.
For example, a health system in Indianapolis, IN that sells a 200,000 SF medical office building for $60 million and leases it back at $18 per square foot annually adds approximately $3.6 million in annual lease expense. Under ASC 842, the present value of that obligation — potentially $30 to $40 million over a 10-year term — appears as a right-of-use liability on the balance sheet. Rating analysts will evaluate whether the proceeds from the sale offset this new obligation sufficiently, and whether the system deploys that capital in a credit-accretive way.
Joint ventures introduce a different dynamic. When a health system contributes real estate to a joint venture — common in outpatient campus developments ranging from 50,000 to 300,000 SF — the structure may or may not consolidate onto the system’s balance sheet depending on ownership percentage and control provisions. Non-consolidating joint ventures can improve leverage optics, but agencies increasingly scrutinize off-balance-sheet arrangements for hidden contingent liabilities.
Key Considerations
Timing relative to existing bond covenants matters significantly. Many health systems carry bond indenture covenants that restrict asset sales above a certain threshold — commonly 5 to 10 percent of total assets — without board approval or bondholder notification. Violating these covenants, even unintentionally through a well-structured real estate transaction, can trigger technical default and immediate rating review. Legal and treasury teams should review indenture language before any transaction closes, ideally 90 to 120 days in advance.
Proceeds deployment is equally critical to rating outcome. Agencies respond more favorably when monetized real estate capital is directed toward debt reduction, facility reinvestment, or clearly defined strategic capital programs. Unallocated proceeds sitting in reserves may signal a lack of strategic clarity, which itself draws rating scrutiny. As outlined in our healthcare real estate advisory services, aligning transaction structure with capital deployment strategy is foundational to a credit-neutral or credit-positive outcome.
Operational continuity provisions in lease agreements also factor into agency analysis. Long-term lease structures — typically 15 to 25 years with renewal options — that guarantee continued clinical access to core facilities are viewed more favorably than shorter arrangements with uncertain renewal terms. Agencies want assurance that access to mission-critical facilities is not contingent on market conditions at lease expiration.
Actionable Takeaway
Before executing any significant healthcare real estate transaction, engage your bond counsel, CFO, and a healthcare-specialized real estate advisor together — not sequentially. The most common error health systems make is structuring a transaction in isolation from treasury and then discovering covenant or rating implications after term sheets are signed. Early coordination, ideally 6 to 12 months before a planned transaction, allows the team to model multiple structures against existing debt covenants, ASC 842 impacts, and credit metric thresholds simultaneously. As explored across Bremner’s healthcare real estate platform, integrated advisory work consistently produces better capital outcomes than siloed deal execution.
One practical tip: request a pre-transaction briefing with your primary rating agency analyst. Moody’s, S&P, and Fitch all offer issuer dialogue processes that allow health system CFOs to discuss strategic transactions informally before they close. This briefing does not lock in a rating outcome, but it surfaces agency concerns early enough to adjust transaction structure. Many health systems underutilize this process. To explore how your system’s real estate portfolio aligns with your current credit strategy, schedule a consultation with our advisory team.
Bremner Real Estate partners with health systems to align real estate strategy with clinical performance and capital efficiency.
Does a sale-leaseback transaction always negatively affect a health system’s bond rating?
Not necessarily. A sale-leaseback can be credit-neutral or even credit-positive if the net proceeds materially reduce outstanding debt or fund capital investments that improve operating performance. The rating impact depends on how proceeds are deployed, the size of the resulting lease obligation relative to the system’s revenue base, and whether the transaction aligns with the system’s stated strategic plan. Agencies evaluate the totality of the transaction, not just the structural change in asset ownership.
How does ASC 842 change the way rating agencies view operating leases in healthcare real estate?
ASC 842, effective for most nonprofit health systems since fiscal year 2020, requires organizations to recognize operating lease obligations as right-of-use assets and liabilities on the balance sheet. Prior to ASC 842, operating leases were disclosed only in footnotes and largely excluded from leverage calculations. Now, analysts at Moody’s, S&P, and Fitch incorporate these on-balance-sheet liabilities directly into debt-to-capitalization and other leverage metrics, making the financial impact of new lease commitments more visible and more consequential to credit analysis.
What dollar threshold typically triggers rating agency review for a healthcare real estate transaction?
There is no universal threshold, as it depends on the health system’s total asset base and existing credit agreements. However, transactions exceeding 5 percent of a system’s total assets commonly trigger disclosure requirements under bond indenture covenants, and many agencies will initiate a formal review of any transaction exceeding $25 to $50 million. Health systems with outstanding rated debt should consult bond counsel to identify the specific thresholds embedded in their indenture documents before entering into any significant real estate agreement.
Can a joint venture structure protect a health system’s bond rating during a real estate transaction?
A joint venture can provide balance sheet protection if it is structured as a non-consolidating entity, meaning the health system holds a minority interest or lacks operational control. In those cases, the joint venture’s debt and liabilities do not appear on the health system’s consolidated balance sheet. However, rating agencies have become more rigorous about evaluating off-balance-sheet arrangements, particularly if the health system has provided guarantees, letters of credit, or backstop commitments to the joint venture. Full transparency with your rating analyst about JV structure is essential.
How far in advance should a health system begin planning a real estate transaction with bond rating implications in mind?
Health systems should begin integrated planning — including treasury, legal, clinical operations, and real estate advisory — 6 to 12 months before a target transaction close date. This lead time allows for covenant review, financial modeling under multiple transaction structures, potential agency dialogue, and board-level approval processes that many bond indentures require. Transactions pursued on compressed timelines frequently encounter structural complications that either delay closing or require renegotiation, both of which create reputational and credit uncertainty with the capital markets.